GMP Requirements
This page summarises the core Good Manufacturing Practice (GMP) requirements under NOM-241-SSA1-2025 for medical device manufacturers, importers, and supply chain partners in Mexico.
Management responsibilityβ
- Establish and document a quality policy and quality objectives.
- Define organisational structure and responsibilities for quality.
- Conduct regular management reviews of the quality system.
- Designate a management representative with authority over quality functions.
Design controlsβ
- Maintain documented design and development procedures.
- Conduct design reviews, verification, and validation at appropriate stages.
- Maintain a Design History File (DHF) or equivalent design record.
- Ensure design output meets design input requirements before release.
Document and record controlsβ
- Maintain controlled documents with version history and approval records.
- Retain manufacturing, distribution, and quality records per defined retention periods.
- Ensure traceability from raw materials through to distribution (critical for recalls).
Purchasing controlsβ
- Qualify and monitor approved suppliers for critical components and materials.
- Define supplier quality requirements in purchasing documents or agreements.
- Conduct periodic supplier audits based on risk.
Production and process controlsβ
- Validate manufacturing processes that cannot be fully verified by inspection.
- Monitor and control process parameters at defined control points.
- Maintain batch/lot records traceable to finished device distribution.
CAPA β Corrective and Preventive Actionβ
The CAPA system is the backbone of continuous improvement:
- Identify sources of non-conformity (complaints, audits, process data, technovigilance).
- Investigate root cause.
- Implement corrective actions and verify effectiveness.
- Implement preventive actions to eliminate potential non-conformities.
- All CAPAs must be documented and reviewed by management.
Complaint handling & technovigilance interfaceβ
- Maintain a documented complaint handling procedure.
- All complaints must be assessed for reportability under NOM-240 technovigilance obligations.
- Complaints that meet adverse event criteria must be escalated to the MRH for CNFV reporting.
- Complaint records must be retained and summarised in the Technovigilance Report at renewal.
Chapter 19 β Warehousing & distributionβ
NOM-241 Chapter 19 specifically addresses storage and distribution:
- Temperature and humidity control β storage conditions must be appropriate for each device type and validated.
- Segregation β quarantine, approved, and rejected stock must be physically separated.
- Distribution records β traceable to lot/serial number and customer.
- Returns and complaints β documented handling of returned product.
- Third-party logistics β the MRH/importer retains responsibility even when logistics are outsourced; technical agreements must define responsibilities.
Technical agreements with distributorsβ
NOM-241 requires written technical agreements between the MRH and each distributor, specifying:
- Storage and handling requirements.
- Adverse event reporting obligations and escalation timeframes.
- Record-keeping responsibilities.
- Returns and recall procedures.
- Audit rights.